XL 40 (Cabometyx 40 mg)
Generic Name: cabozantinib
Pill imprint XL 40 has been identified as Cabometyx 40 mg.
Cabometyx is used in the treatment of renal cell carcinoma and belongs to the drug classes multikinase inhibitors, VEGF/VEGFR inhibitors. There is positive evidence of human fetal risk during pregnancy. Cabometyx 40 mg is not a controlled substance under the Controlled Substance Act (CSA).
- Generic Name:
- cabozantinib
- Imprint:
- XL 40
- Strength:
- 40 mg
- Color:
- Yellow
- Shape:
- Three-sided
- Availability:
- Prescription only
- Drug Class:
- Multikinase inhibitors
VEGF/VEGFR inhibitors - Pregnancy Category:
- D - Positive evidence of risk
- CSA Schedule:
- Not a controlled drug
- Manufacturer:
- Exelixis, Inc.
More about Cabometyx (cabozantinib)
- Side Effects
- During Pregnancy
- Dosage Information
- Drug Images
- Drug Interactions
- Support Group
- Pricing & Coupons
- En Español
- 0 Reviews – Add your own review/rating
- Drug class: multikinase inhibitors
Consumer resources
Other brands: Cometriq
Professional resources
Related treatment guides
Disclaimer:
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2017 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.
